Lineage of drug discovery research on fluorinated pyrimidines: chronicle of the achievements accomplished by Professor Setsuro Fujii

Int J Clin Oncol. 2023 May;28(5):613-624. doi: 10.1007/s10147-023-02326-w. Epub 2023 Mar 24.

Abstract

Prof. Setsuro Fujii achieved significant results in the field of drug discovery research in Japan. He developed nine well-known drugs: FT, UFT, S-1 and FTD/TPI are anticancer drugs, while cetraxate hydrochloride, camostat mesilate, nafamostat mesilate, gabexate mesilate and pravastatin sodium are therapeutic drugs for various other diseases. He delivered hope to patients with various diseases across the world to improve their condition. Even now, drug discovery research based on Dr. Fujii's ideas is continuing.

Keywords: 5-Fluorouracil; Camostat mesilate; Cancer chemotherapy; Cetraxate hydrochloride; Gabexate mesilate; Nafamostat mesilate; Pravastatin sodium; Senescence; Tegafur; Tegafur and uracil; Tegafur, gimeracil and oteracil; Trifluridine and tipiracil hydrochloride.

MeSH terms

  • Antineoplastic Agents* / therapeutic use
  • Gabexate* / therapeutic use
  • Humans
  • Japan
  • Male
  • Pyrimidines
  • Tegafur / therapeutic use
  • Uracil

Substances

  • Pyrimidines
  • Gabexate
  • Antineoplastic Agents
  • Tegafur
  • Uracil